Ben Derman (@bdermanmd) 's Twitter Profile
Ben Derman

@bdermanmd

Asst Professor at University of Chicago, specializing in (vanquishing) plasma cell disorders. I tweet about: Myeloma & MRD. linktr.ee/bderman

ID: 872983600416862208

calendar_today09-06-2017 01:08:04

3,3K Tweet

3,3K Followers

374 Following

Ben Derman (@bdermanmd) 's Twitter Profile Photo
Ben Derman
@bdermanmd

3 months ago

Another challenge with trial enrollment. Most trials restrict enrollment to patients who have an M spike of 1 g/dL or free light chains of at least 10 mg/dL to enable full response adjudication. But patients with ‘oligosecretory’ disease are excluded. This becomes especially